A Novel RAC2 Mutation Causing Combined Immunodeficiency

被引:4
|
作者
Zhang, Liang [1 ,2 ]
Lv, Ge [3 ,4 ,5 ]
Peng, Yu [2 ,6 ]
Yang, Lu [3 ,4 ,5 ]
Chen, Junjie [3 ,4 ,5 ]
An, Yunfei [3 ,4 ,5 ]
Zhang, Zhiyong [3 ,4 ,5 ]
Tang, Xuemei [3 ,4 ,5 ]
Li, Zhihui [1 ,2 ]
Zhao, Xiaodong [3 ,4 ,5 ]
机构
[1] Hunan Childrens Hosp, Dept Nephrol Rheumatol & Immunol, Changsha, Hunan, Peoples R China
[2] Univ South China, Sch Pediat, Hengyang Med Sch, Hengyang, Hunan, Peoples R China
[3] Chongqing Med Univ, Childrens Hosp, Key Lab Child Dev & Disorders,China Int Sci & Tec, Dept Pediat Res Inst,Minist Educ,Natl Clin Res Ct, Chongqing, Peoples R China
[4] Chongqing Med Univ, Childrens Hosp, Chongqing Key Lab Child Infect & Immun, Chongqing, Peoples R China
[5] Chongqing Med Univ, Div Rheumatol & Immunol, Childrens Hosp, Chongqing, Peoples R China
[6] Hunan Childrens Hosp, Dept Pediat Res Inst, Changsha, Hunan, Peoples R China
关键词
Ras-related C3 botulinum toxin substrate 2 (RAC2); Combined immunodeficiency; gain-of-function mutation; penetrance; RHO-GTPASES; SUSCEPTIBILITY; HEMATOPOIESIS; PATHWAYS; INSIGHTS; IMMUNITY; PATIENT;
D O I
10.1007/s10875-022-01373-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose Ras-related C3 botulinum toxin substrate 2 (RAC2) acts as a molecular switch and has crucial roles in cell signaling and actin dynamics. A broad spectrum of genetic RAC2 mutations can cause various types of primary immunodeficiency, with complete penetrance. Here, we report a novel heterozygous missense mutation in RAC2 with incomplete penetrance, and the associated phenotypes, in a Chinese family. Methods Immunological phenotype was detected by flow cytometry. T cell receptor excision circles (TRECs) and K-deleting recombination excision circles (KRECs) were assessed by real-time quantitative PCR. Gene mutations were detected by whole-exome sequencing (WES) and confirmed by Sanger sequencing. Results The proband was an 11-year-old girl who presented with recurrent respiratory infections, bronchiectasis, persistent Epstein-Barr virus viremia, infectious mononucleosis, encephalitis, and cutaneous human papillomavirus infections. Laboratory analyses revealed increased serum IgG and decreased IgM levels, reduced naive CD4(+) and CD8(+) T cells, an inverted CD4(+)/CD8(+) ratio, and low TREC and KREC numbers. The mutation resulted in increased production of reactive oxygen species, while impaired actin polarization in neutrophils; diminished proliferative responses, increased cytokine production and a dysregulated phenotype in T lymphocytes; as well as accelerated apoptosis and hyperactivity of AKT in HL-60 human leukemia cells. WES identified a c.44G > A mutation in RAC2 resulting in a p.G15D substitution. Despite sharing the same mutation as the proband, her father suffered from recurrent respiratory infections and bronchiectasis, and had similar immunological defects, whereas her sister was apparently healthy, other than cutaneous human papillomavirus infections, and only mild immunological defects were detected preliminarily. Conclusions Our findings broaden the clinical and genetic spectra of RAC2 mutations and underline the importance of RAC2 gain-of-function mutations with complete or incomplete penetrance.
引用
收藏
页码:229 / 240
页数:12
相关论文
共 50 条
  • [21] Rac2 expression and mutation in human brain tumors
    Hwang, SL
    Lieu, AS
    Chang, JH
    Cheng, TS
    Cheng, CY
    Lee, KS
    Lin, CL
    Howng, SL
    Hong, YR
    ACTA NEUROCHIRURGICA, 2005, 147 (05) : 551 - 554
  • [22] Rac2 expression and mutation in human brain tumors
    S.-L. Hwang
    A.-S. Lieu
    J.-H. Chang
    T.-S. Cheng
    C.-Y. Cheng
    K.-S. Lee
    C.-L. Lin
    S.-L. Howng
    Y.-R. Hong
    Acta Neurochirurgica, 2005, 147 : 551 - 554
  • [23] Progressive multifocal leukoencephalopathy in a patient with novel mutation in the RAC2 gene: a case report
    Sima Bahrami
    Saba Arshi
    Mohammad Nabavi
    Mohammad Hassan Bemanian
    Morteza Fallahpour
    Afshin Rezaeifar
    Sima Shokri
    Journal of Medical Case Reports, 16
  • [24] Progressive multifocal leukoencephalopathy in a patient with novel mutation in the RAC2 gene: a case report
    Bahrami, Sima
    Arshi, Saba
    Nabavi, Mohammad
    Bemanian, Mohammad Hassan
    Fallahpour, Morteza
    Rezaeifar, Afshin
    Shokri, Sima
    JOURNAL OF MEDICAL CASE REPORTS, 2022, 16 (01)
  • [25] RAC2 gain-of-function mutations causing immunodeficiency drive activation of the NLRP3 inflammasome
    Doye, Anne
    Chaintreuil, Paul
    Verhoeyen, Els
    Boyer, Laurent
    M S-MEDECINE SCIENCES, 2025, 41 (02): : 133 - 135
  • [26] Rac2 expression and mutation in human brain tumors - Comment
    Mooij, JJA
    ACTA NEUROCHIRURGICA, 2005, 147 (05) : 554 - 554
  • [27] Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency
    Williams, DA
    Tao, W
    Yang, FC
    Kim, C
    Gu, Y
    Mansfield, P
    Levine, JE
    Petryniak, B
    Derrow, CW
    Harris, C
    Jia, BQ
    Zheng, Y
    Ambruso, DR
    Lowe, JB
    Atkinson, SJ
    Dinauer, MC
    Boxer, L
    BLOOD, 2000, 96 (05) : 1646 - 1654
  • [28] A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease
    Smits, B. M.
    Lelieveld, P. H. C.
    Ververs, F. A.
    Turkenburg, M.
    de Koning, C.
    van Dijk, M.
    Leavis, H. L.
    Boelens, J. J.
    Lindemans, C. A.
    Bloem, A. C.
    van de Corput, L.
    van Montfrans, J.
    Nierkens, S.
    van Gijn, M. E.
    Geerke, D. P.
    Waterham, H. R.
    Koenderman, L.
    Boes, M.
    CLINICAL IMMUNOLOGY, 2020, 212 : 120 - 122
  • [29] POLYMERASE EPSILON 1 MUTATION CAUSING COMBINED IMMUNODEFICIENCY
    Raje, Nikita
    Thiffault, Isabelle
    Saunders, Carol
    Jenkins, Janda
    Canty, Kristi
    Sharma, Mukta
    Grote, Lauren
    Welsh, Holly I.
    Farrow, Emily
    Miller, Neil A.
    Zwick, David
    Zellmer, Lee
    Kingsmore, Stephen F.
    Safina, Nicole P.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 (03) : 328 - 328
  • [30] An inhibitory RAC2 mutation described in human neutrophil immunodeficiency syndrome is not present in patients with severe congenital neutropenia (Kostmann syndrome).
    Tidow, N
    Brandt, BH
    Kasper, B
    Welte, K
    BLOOD, 2000, 96 (11) : 33B - 33B